TREATMENT FOR NON-HODGKINS-LYMPHOMA IN RELAPSE - WHAT ARE THE ALTERNATIVES

被引：5

作者：

VOSE, JM

机构：

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1995年 / 333卷 / 23期

关键词：

D O I：

10.1056/NEJM199512073332312

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1565 / 1566

页数：2

共 10 条

[1]

APPELBAUM FR, 1978, BLOOD, V52, P85

[2] COMPARISON OF A STANDARD REGIMEN (CHOP) WITH 3 INTENSIVE CHEMOTHERAPY REGIMENS FOR ADVANCED NON-HODGKINS-LYMPHOMA [J].

FISHER, RI ;

GAYNOR, ER ;

DAHLBERG, S ;

OKEN, MM ;

GROGAN, TM ;

MIZE, EM ;

GLICK, JH ;

COLTMAN, CA ;

MILLER, TP .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (14) :1002-1006

[3] RADIOIMMUNOTHERAPY OF B-CELL LYMPHOMA WITH [I-131] ANTI-B1 (ANTI-CD20) ANTIBODY [J].

KAMINSKI, MS ;

ZASADNY, KR ;

FRANCIS, IR ;

MILIK, AW ;

ROSS, CW ;

MOON, SD ;

CRAWFORD, SM ;

BURGESS, JM ;

PETRY, NA ;

BUTCHKO, GM ;

GLENN, SD ;

WAHL, RL .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (07) :459-465

[4] P-GLYCOPROTEIN EXPRESSION IN MALIGNANT-LYMPHOMA AND REVERSAL OF CLINICAL DRUG-RESISTANCE WITH CHEMOTHERAPY PLUS HIGH-DOSE VERAPAMIL [J].

MILLER, TP ;

GROGAN, TM ;

DALTON, WS ;

SPIER, CM ;

SCHEPER, RJ ;

SALMON, SE .

JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (01) :17-24

[5] AUTOLOGOUS BONE-MARROW TRANSPLANTATION AS COMPARED WITH SALVAGE CHEMOTHERAPY IN RELAPSES OF CHEMOTHERAPY-SENSITIVE NON-HODGKINS-LYMPHOMA [J].

PHILIP, T ;

GUGLIELMI, C ;

HAGENBEEK, A ;

SOMERS, R ;

VANDERLELIE, H ;

BRON, D ;

SONNEVELD, P ;

GISSELBRECHT, C ;

CAHN, JY ;

HAROUSSEAU, JL ;

COIFFIER, B ;

BIRON, P ;

MANDELLI, F ;

CHAUVIN, F .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (23) :1540-1545

[6] A PHASE-II TRIAL OF MESNA IFOSFAMIDE, MITOXANTRONE AND ETOPOSIDE FOR REFRACTORY LYMPHOMAS [J].

RODRIGUEZ, MA ;

CABANILLAS, FC ;

HAGEMEISTER, FB ;

MCLAUGHLIN, P ;

ROMAGUERA, JE ;

SWAN, F ;

VELASQUEZ, W .

ANNALS OF ONCOLOGY, 1995, 6 (06) :609-611

[7] INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE IN RELAPSED AND RESISTANT NON-HODGKINS-LYMPHOMA - EVIDENCE FOR A SCHEDULE-DEPENDENT EFFECT FAVORING INFUSIONAL ADMINISTRATION OF CHEMOTHERAPY [J].

SPARANO, JA ;

WIERNIK, PH ;

LEAF, A ;

DUTCHER, JP .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (06) :1071-1079

[8] ESHAP - AN EFFECTIVE CHEMOTHERAPY REGIMEN IN REFRACTORY AND RELAPSING LYMPHOMA - A 4-YEAR FOLLOW-UP-STUDY [J].

VELASQUEZ, WS ;

MCLAUGHLIN, P ;

TUCKER, S ;

HAGEMEISTER, FB ;

SWAN, F ;

RODRIGUEZ, MA ;

ROMAGUERA, J ;

RUBENSTEIN, E ;

CABANILLAS, F .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (06) :1169-1176

[9]

VELASQUEZ WS, 1988, BLOOD, V71, P117

[10]

Zhan Z., 1993, Proceedings of the American Association for Cancer Research Annual Meeting, V34, P215

← 1 →